These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2635343)

  • 1. Effects of hypoxia and complement activation on lung hemodynamics and fluid exchanges in unanesthetized goats.
    Xie ZL; Sun BY; Li DQ
    Respiration; 1989; 56(3-4):147-53. PubMed ID: 2635343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrhagic shock prevents lung microvascular permeability and hypoxemia associated with complement activation in the awake sheep.
    Krausz MM; Shilo L; Moriel E; Perel A; Eldor A; Durst AL
    Circ Shock; 1987; 23(1):7-26. PubMed ID: 3690815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-mediated pulmonary edema in sheep.
    Egan TM; Saunders NR; Luk SC; Cooper JD
    J Surg Res; 1988 Aug; 45(2):204-14. PubMed ID: 3404983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zymosan activation of plasma reduces hypoxic pulmonary vasoconstriction.
    Weir EK; Tierney JF; Chesler E; Lundquist LJ; Craddock PR
    Respir Physiol; 1983 Sep; 53(3):295-306. PubMed ID: 6648060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CVF-induced decomplementation: effect on lung transvascular protein flux after thrombin.
    Johnson A; Lo SK; Blumenstock FB; Malik AB
    J Appl Physiol (1985); 1987 Mar; 62(3):863-9. PubMed ID: 3032888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alveolar hypoxia on lung fluid and protein transport in unanesthetized sheep.
    Bland RD; Demling RH; Selinger SL; Staub NC
    Circ Res; 1977 Mar; 40(3):269-74. PubMed ID: 13942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a single infusion of zymosan-activated plasma on the pulmonary microcirculation of sheep. Structure-function relationships.
    Meyrick BO; Brigham KL
    Am J Pathol; 1984 Jan; 114(1):32-45. PubMed ID: 6691415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of an infusion of zymosan-activated plasma on hemodynamic and pulmonary function in sheep.
    Sharkey P; Judges D; Driedger AA; Cheung H; Finley RJ; Sibbald WJ
    Circ Shock; 1984; 12(2):79-93. PubMed ID: 6705153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of therapy with 2,3-dihydroxybenzoic acid to modify the course of sepsis-induced lung injury.
    Sharpe MD; Mustard RA; Finley RR; Rutledge FS; Sibbald WJ
    J Appl Physiol (1985); 1990 Nov; 69(5):1893-902. PubMed ID: 2272983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-reoxygenation potentiates zymosan activated plasma-induced endothelial injury.
    Gupta N; Jacobs DL; Miller TA; Smith GS; Dahms TE
    J Surg Res; 1998 Jul; 77(2):91-8. PubMed ID: 9733593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repetitive bolus injections of zymosan-activated plasma on lung mechanics and airway responsiveness in awake sheep.
    Snapper JR; Butterfield MJ; Rayburn DB; Lefferts PL
    Am Rev Respir Dis; 1991 Mar; 143(3):578-84. PubMed ID: 2001069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute hypoxia on lung fluid balance in the prerecruited dog lung.
    Martin DJ; Baconnier P; Benchetrit G; Royer F; Grimbert FA
    Bull Eur Physiopathol Respir; 1986; 22(4):335-40. PubMed ID: 3768567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
    Smallbone BW; Taylor NE; McDonald JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1035-40. PubMed ID: 2821222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary microvascular response to prostacyclin (PGI2) infusion in unanesthetized sheep.
    Gunther R; Zaiss C; Demling RH
    J Appl Physiol Respir Environ Exerc Physiol; 1982 May; 52(5):1338-42. PubMed ID: 7047472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 prevents increased lung microvascular permeability during intravascular complement activation in sheep.
    Gee MH; Tahamont MV; Flynn JT; Cox JW; Pullen RH; Andreadis NA
    Circ Res; 1987 Sep; 61(3):420-8. PubMed ID: 3621501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane as a mediator of pulmonary dysfunction during intravascular complement activation in sheep.
    Gee MH; Perkowski SZ; Tahamont MV; Flynn JT; Wasserman MA
    Am Rev Respir Dis; 1986 Feb; 133(2):269-73. PubMed ID: 3753832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diethylcarbamazine on pulmonary vascular response to endotoxin in awake sheep.
    Zadoff AD; Kobayashi T; Brigham KL; Newman JH
    J Appl Physiol (1985); 1986 Apr; 60(4):1380-5. PubMed ID: 3754554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species variability in the cardiovascular and hematologic effects of zymosan-activated plasma infusion.
    Casey LC; Fletcher JR; Chernow B; Ramwell PW
    J Surg Res; 1986 Mar; 40(3):202-9. PubMed ID: 3951216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of complement activation with cobra venom factor on pulmonary vascular permeability.
    Johnson A; Cooper JA; Malik AB
    J Appl Physiol (1985); 1986 Dec; 61(6):2202-9. PubMed ID: 3027023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary vascular and hemodynamic effects of prostaglandin E1 in unanesthetized sheep.
    Ogletree ML; Brigham KL
    Microcirc Endothelium Lymphatics; 1984 Jun; 1(3):307-27. PubMed ID: 6546148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.